Prescription drug · ANDA
Glipizide and Metformin HCl NDC 71205-270
Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1 · Tablet, Film coated · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-270-30 | 71205027030 | 30 TABLET, FILM COATED in 1 BOTTLE (71205-270-30)Marketed from May 1, 2019 | |
| 71205-270-60 | 71205027060 | 60 TABLET, FILM COATED in 1 BOTTLE (71205-270-60)Marketed from May 1, 2019 | |
| 71205-270-90 | 71205027090 | 90 TABLET, FILM COATED in 1 BOTTLE (71205-270-90)Marketed from May 1, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glipizide and Metformin HCl
- Generic name (nonproprietary)
- glipizide and metformin hcl
- Active ingredients
- Glipizide — 5 mg/1Metformin hydrochloride — 500 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078728
- Marketing start
- Listing expires
- Other FDA classes
- Biguanides (Chemical structure)Sulfonylurea Compounds (Chemical structure)
- Identifiers
- Product ID 71205-270_ba23a55b-30dd-4d55-a423-3542524a8efeSPL ID ba23a55b-30dd-4d55-a423-3542524a8efeSPL set ID be4d2552-c964-4d09-ba7a-0d94320f968cRxCUI 861740UNII X7WDT95N5C, 786Z46389E
- Pharmacologic class
- Biguanide; Sulfonylurea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205027030followed by a unit qualifier and the quantityPackage 71205-0270-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Glipizide and Metformin HCl Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 078728
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glipizide and Metformin HCl | Glipizide 2.5 mg/1; Metformin hydrochloride 250 mg/1 | Tablet, Film coatedOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-115 |
| Glipizide and Metformin HCl | Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-116 |
| Glipizide and Metformin HCl | Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-117 |
| Glipizide and metformin hcl | Glipizide 2.5 mg/1; Metformin hydrochloride 250 mg/1 | Tablet, Film coatedOral | Chartwell RX, LLC | 62135-731 |
| Glipizide and metformin hcl | Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Chartwell RX, LLC | 62135-732 |
| Glipizide and metformin hcl | Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Chartwell RX, LLC | 62135-733 |